Charles "Rusty" Holden practiced law from 1975 to 2004. He received a BA in political science from University of California, Berkeley in 1972 followed by a JD from Hastings College of the Law in 1975. In 2005 he contracted with National Laboratories to perform computational studies concerning thorium fuels and production of medical isotopes. The computational studies developed ways to make medical isotopes with the guidance of Dr. Schenter.

Michael Ullman has more than 30 years of experience in the pharmaceutical and biotechnology sectors. Mr. Ullman was Managing Director at Burrill & Company, a life sciences venture capital firm. Mr. Ullman headed Biovector Therapeutics, Liposome Technology /SEQUUS Pharmaceuticals, Inc. He started at Bristol-Myers Squibb Corporation. He received BS in Pharmaceutical Science from Drake University in 1967 and MBA from University of Illinois in 1971.

Phil Husby has over 40 years of professional experience providing financial, accounting and tax services to technology companies. He is a CPA has held CFO positions at many public and private companies and has extensive international experience. He has been associated with KPMG, Tatum LLC, Big Fix, Inc, Iomega and Ogden Corporation. He received his BS in accounting from University of San Francisco in 1968 and MBA from US Berkeley.

Dr. Rick Wittman holds a doctorate in theoretical nuclear physics from Rensselaer Polytechnic Institute competed in 1986. He has deep experience with predictive modeling and data analysis of physical systems.. He is responsible for performing isotope production calculations and provide modeling support to the Radiochemical Processing Laboratory at Pacific Northwest National Laboratory. Dr. Wittman has performed computational studies supporting Th